An italian biopharmaceutical company for Monoclonal Antibodies - Business development

info@mediapharma.it Contact Media Pharma

An italian biopharmaceutical company

The company is focused on the discovery, development and commercialization of monoclonal antibodies

HOME » BUSINESS DEVELOPMENT

Business development

...

...

Last updated: 08/06/2009 19:07

Highlights

MediaPharma S.r.l.

A Company focused on the discovery, development and commercialization of monoclonal antibodies for the diagnosis and treatment of cancer and other diseases with unmet medical need.
Updated | 26/05/2010 16:04
Personalized medicine

At the present, one of the major problems in cancer treatment lies in the lack of suitable assays to select patients more likely to respond to a given anticancer therapy
Updated | 26/11/2009 11:11

Subscribe to Rss Feed
Share

MediaPharma s.r.l. P.IVA.: IT 02282760699 | Rea di Chieti: 166532
The information provided on www.mediapharma.it is designed to complement, not replace, the relationship between a patient and his/her own physician.